Effects of lysophosphatidic acid on the in vitro proliferation and differentiation of a novel porcine preadipocyte cell line

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 157, Issue 4, 2010, Pages 401-407

  Nobusue, Hiroyuki ^a   Kondo, Daisuke ^a,b   Yamamoto, Makiko ^b   Kano, Koichiro ^a  

^a NIHON UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Adipocyte; Differentiation; LPA; Porcine; Preadipocyte; Proliferation

Indexed keywords

CELL RECEPTOR; ENDOTHELIAL DIFFERENTIATION GENE 2 RECEPTOR; ENDOTHELIAL DIFFERENTIATION GENE 4 RECEPTOR; ENDOTHELIAL DIFFERENTIATION GENE 7 RECEPTOR; FAT DROPLET; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LYSOPHOSPHATIDIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION;

ANIMALIA; SUS;

EID: 77957907103     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpb.2010.08.010     Document Type: Article

References (47)

1. Ailhaud G., Grimaldi P., Negrel R. A molecular view of adipose tissue. Int. J. Obes. Relat. Metab. Disord. 1992, 16:S17-S21.
2. An S., Dickens M.A., Bleu T., Hallmark O.G., Goetzl E.J. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun. 1997, 231:619-622.
3. An S., Bleu T., Hallmark O., Goetzl E. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 1998, 273:7906-7910.
4. Bandoh K., Aoki J., Hosono H., Kobayashi S., Murakami-Murofushi K., Tsujimoto M., Arai H., Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 1999, 274:27776-27785.
5. Bennett A.M., Tonks N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997, 278:1288-1291.
6. Contos J.J., Chun J. Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA. Genomics 2000, 64:155-169.
7. Coolican S.A., Samuel D.S., Ewton D.Z., McWade F.J., Florini J.R. The mitogenic and myogenic actions of inslin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 1997, 272:6653-6662.
8. Freytag S.O. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol. Cell. Biol. 1988, 8:1614-1624.
9. Fev B. Adipogenesis: cellular and molecular aspects. Best Pract. Res. Cli. Endocrinol. Metab. 2005, 19:483-499.
10. Font de Mora J., Porras A., Ahn N., Santos E. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocyte differentiation. Mol. Cell. Biol. 1997, 17:6068-6075.
11. Green H., Kehinde O. An established pre-adipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
12. Green H., Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 1976, 7:105-113.
13. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3:127-133.
14. Hansen J.B., Petersen R.K., Jorgensen C., Kristiansen K. Deregulated MAPK activity prevents adipocyte differentiation of fibroblasts lacking the retinoblastoma protein. J. Biol. Cem. 2002, 277:26335-26339.
15. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 1996, 135:1071-1083.
16. Hordijk P.L., Verlaan I., van Corven E.J., Moolenaar W.H. Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. J. Biol. Chem. 1994, 269:645-651.
17. Hu E., Kim J.B., Sarraf P., Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 1996, 274:2100-2103.
18. Im D.S., Heise C.E., Harding M.A., George S.R., O'Dowd B.F., Theodorescu D., Lynch K.R. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol. Pharmacol. 2000, 57:753-759.
19. Ishii I., Fukushima N., Ye X., Chun J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 2004, 73:321-354.
20. Koellensperger E., von Heimburg D., Markowicz M., Pallua N. Human serum from platelet-poor plasma for the culture of primary human preadipocytes. Stem Cell 2006, 24:1218-1225.
21. Kozak L.P., Jensen J.T. Genetic and developmental control of multiple forms of l-glycerol 3-phosphate dehydrogenase. J. Biol. Chem. 1974, 249:7775-7781.
22. Kranenburg O., Moolenaar W.H. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 2001, 20:1540-1546.
23. Larsen M.O., Rolin B. Use of the Gottingen minipig as a model of diabetes, with special focus on type I diabetes research. ILAR J. 2004, 45:303-313.
24. Leshem Y., Gitelman I., Ponzetto C., Halevy O. Preferential binding of Grb2 or phosphatidylinositol 3-kinase to the met receptor has opposite effects on HGF-induced myoblast proliferation. Exp. Cell Res. 2002, 274:288-298.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the folin phenol regent. J. Biol. Chem. 1951, 193:265-275.
26. Lunney J.K. Advances in swine biomedical model genomics. Int. J. Biol. Sci. 2007, 3:179-184.
27. Moolenaar W.H., Kranenburg O., Postma F.R., Zondag G.C. Lysophosphatidic acid: G-protein signaling and cellular responses. Curr. Opin. Cell Biol. 1997, 9:168-173.
28. Nobusue H., Kano K. Establishment and characteristics of porcine preadipocyte cell lines derived from matre adipocytes. J. Cell. Biochem. 2010, 109:542-552.
29. Nobusue H., Endo T., Kano K. Establishment of a preadipocyte cell line derived from mature adipocytes of GFP transgenic mice and formation of adipose tissue. Cell Tissue Res. 2008, 332:435-446.
30. Noguchi M., Hosoda K., Fujikura J., Fujimoto M., Iwakura H., Tomita T., Ishii T., Arai N., Hirata M., Ebihara K., Masuzaki H., Itoh H., Narumiya S., Nakao K. Genetic and pharmacological inhibition of Rho-associated kinase 2 enhances adipogenesis. J. Biol. Chem. 2007, 282:29574-29583.
31. Ntambi J.M., Young-Cheul K. Adipocyte differentiation and gene expression. J. Nutr. 2000, 130:3122-3126.
32. Pages C., Daviaud D., An S., Krief S., Lafontan M., Valet P., Saulnier-Blache J.S. Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3-F442A preadipocyte proliferation and spreading. J. Biol. Chem. 2001, 265:11599-11605.
33. Pang W.J., Yu T.Y., Bai L., Yang Y.J., Yang G.S. Tissue expression of porcine FoxO1 and its negative regulation during primary preadipocyte differentiation. Mol. Biol. Rep. 2009, 36:165-176.
34. Rodway H.A., Hunt A.N., Kohler J.A., Postle A.D., Lillycrop K.A. Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12, 14-prostaglandin J2 in neuroblastoma cells. Biochem. J. 2004, 382:83-91.
35. Rommel C., Clarke B.A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G.D., Glass D.J. Differentiation stage-specific inhibition of the Ras-MEK-ERK pathway by Akt. Science 1999, 286:1738-1741.
36. Sanosaka M., Minashima T., Suzuki K., Watanabe K., Ohwada S., Hagio A., Rose M.T., Yamaguchi T., Aso H. A combination of octanoate and oleate promotes in vitro differentiation of porcine intramuscular adipocytes. Comp. Biochem. Physiol. A. 2008, 149:285-292.
37. Simon M.F., Daviaud D., Pradere J.P., Gres S., Guigne C., Wabitsch M., Chun J., Valet P., Saulnier-Blache J.S. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. J. Biol. Chem. 2005, 280:14656-14662.
38. Smas C.M., Sul H.S. Control of adipocyte differentiation. Biochem. J. 1995, 309:697-710.
39. Sordella R., Jiang W., Chen G.C., Curto M., Settleman J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 2003, 113:147-158.
40. Spiegelman B.M., Flier J. Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87:377-389.
41. Takuwa Y., Takuwa N., Sugimoto N. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J. Biochem. 2002, 131:767-771.
42. Tomlinson J.J., Boudreau A., Wu D., Hache R.J. Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology 2006, 147:5284-5293.
43. Valet P., Pages C., Jeanneton O., Daviaud D., Barbe P., Record M., Saulnier-Blache J.S., Lafontan M. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. J. Clin. Invest. 1998, 101:1431-1438.
44. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 1989, 59:45-54.
45. van Corven E.J., Hordijk P.L., Medema R.H., Bos J.L., Moolenaar W.H. Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:1257-1261.
46. Wise L.S., Green H. Participation of one isozyme of glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J. Biol. Chem. 1979, 254:273-275.
47. Yoshida S., Fujisawa-Sehara A., Taki T., Arai K., Nabeshima Y. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts. J. Cell Biol. 1996, 132:181-193.